Growth Metrics

Jazz Pharmaceuticals (JAZZ) Change in Inventory (2016 - 2025)

Jazz Pharmaceuticals has reported Change in Inventory over the past 16 years, most recently at -$7.7 million for Q4 2025.

  • Quarterly Change in Inventory fell 141.36% to -$7.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86.0 million through Dec 2025, up 88.93% year-over-year, with the annual reading at $86.0 million for FY2025, 88.93% up from the prior year.
  • Change in Inventory was -$7.7 million for Q4 2025 at Jazz Pharmaceuticals, down from $31.9 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $35.6 million in Q1 2025 and troughed at -$7.7 million in Q4 2025.
  • The 5-year median for Change in Inventory is $8.9 million (2022), against an average of $12.2 million.
  • Biggest five-year swings in Change in Inventory: skyrocketed 1229.42% in 2024 and later crashed 141.36% in 2025.
  • Tracing JAZZ's Change in Inventory over 5 years: stood at $15.0 million in 2021, then plummeted by 105.45% to -$816000.0 in 2022, then soared by 272.06% to $1.4 million in 2023, then skyrocketed by 1229.42% to $18.7 million in 2024, then crashed by 141.36% to -$7.7 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$7.7 million, $31.9 million, and $26.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.